Comparison of cell death-inducing effect of novel taxane SB-T-1216 and paclitaxel in breast cancer cells

Anticancer Research

Volumn 29, Issue 8, 2009, Pages 2951-2960

  Kovář, Jan ^a   Ehrlichová, Marie ^b   Šmejkalová, Barbora ^c   Zanardi, Ilaria ^d   Ojima, Iwao ^d   Gut, Ivan ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^c INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

^d STONY BROOK UNIVERSITY   (United States)

Author keywords

Breast cancer cells; Caspases; Cell cycle; Cell death; Microtubule bundles; Paclitaxel; Taxane SB T 1216

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE; CASPASE 2; CASPASE 3; CASPASE 8; CASPASE 9; PACLITAXEL; SBT 1216; TAXANE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL DEATH; CELL GROWTH; CELL SURVIVAL; COLORIMETRY; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IC 50; INTERPHASE; MICROTUBULE; PRIORITY JOURNAL;

ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BREAST NEOPLASMS; CASPASE 2; CASPASE 3; CASPASE 8; CASPASE 9; CELL DIVISION; CELL LINE, TUMOR; CELL PROLIFERATION; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; G1 PHASE; G2 PHASE; HUMANS; MICROSCOPY, FLUORESCENCE; MICROTUBULES; PACLITAXEL; TAXOIDS;

EID: 68549115311     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Rowinsky EK: The development and clinical utility of taxane class of antimicrotubule chemotherapy agents. Annu Rev Med 48: 353-374, 1997.
2. Vaishampayan U, Parchment RE, Jasti BR and Hussain M: Taxanes: an overview of the pharmacokinetics and pharmacodynamics. Urology 54: 22-29, 1999.
3. Choy H: Taxanes in combined modality therapy for solid tumors. Crit Rev Oncol Hematol 37: 237-247, 2001. (Pubitemid 32194421)
4. Miller ML and Ojima I: Chemistry and chemical biology of taxane anticancer agents. Chem Record 1: 195-211, 2001.
5. Ganansia-Leymarie V, Bischoff P, Bergerat JP and Holl V: Signal transduction pathways of taxane-induced apoptosis. Curr Med Chem Anticancer Agents 3: 291-306, 2003. (Pubitemid 36758303)
6. Orr GA, Verdier-Pinard P, McDaid H and Horwitz SB: Mechanisms of taxol resistance related to microtubules. Oncogene 22: 7280-7295, 2003. (Pubitemid 37487160)
7. Tuszynski JA, Trpišová B, Sept D and Brown JA: Selected physical issues in the structure and function of microtubules. J Struct Biol 118: 94-106, 1997. (Pubitemid 27208265)
8. Brinkley BR: Managing the centrosome numbers game: from chaos to stability in cancer cell division. Trends Cell Biol 11: 18-21, 2001.
9. Spencer MC and Faulds D: Paclitaxel: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer. Drugs 48: 795-845, 1994.
10. Xiao H, Verdier-Pinard P, Fernandez-Fuentes N, Burd B, Angeletti R, Fiser A, Horwitz SB and Orr GA: Insights into the mechanism of microtubule stabilization by Taxol. Proc Natl Acad Sci USA 103: 10166-10173, 2006. (Pubitemid 44051138)
11. Larroque AL, Dubois J, Thoret S, Aubert G, Chiaroni A, Guéritte F and Guénard D: Novel C2-C3′ N-peptide-linked macrocyclic taxoids. Part 2: synthesis and biological activities of docetaxel analogues with a peptide side chain at C2 and their macrocyclic derivatives. Bioorg Med Chem 15: 563-574, 2007.
12. Sackett D and Fojo T: Taxanes. Cancer Chemother Biol Response Modif 17: 59-79, 1997.
13. Jordan MA, Ojima I, Rosas F, Distefano M, Wilson L, Scambia G and Ferlini C: Effects of novel taxanes SB-T-1213 and IDN5109 on tubulin polymerization and mitosis. Chem Biol 9: 93-101, 2002. (Pubitemid 34155868)
14. Fan W: Possible mechanisms of paclitaxel-induced apoptosis. Biochem Pharmacol 57: 1215-1221, 1999.
15. Aoudjit F and Vuori K: Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cells. Oncogene 20: 4995-5004, 2001. (Pubitemid 32769789)
16. Ehrlichová M, Koc M, Truksa J, Nad'ová Z, Václavíková R and Kovář J: Cell death induced by taxanes in breast cancer cells: cytochrome c is released in resistant but not in sensitive cells. Anticancer Res 25: 4215-4224, 2005.
17. Nicoletti MI, Colombo T, Rossi C, Monardo C, Stura S, Zucchetti M, Riva A, Morazzoni P, Donati MB, Bombardelli E, D'Incalci M and Giavazzi R: IDN5109, a taxane with oral bioavailability and potent antitumor activity. Cancer Res 60: 842-846, 2000. (Pubitemid 30129512)
18. Ojima I, Slater JC, Michand E, Kuduk SD, Bounaud P-Y, Vrignaud P, Bissery M-C, Veith JM, Pera P and Bernacki RJ: Synthesis and structure-activity relationships of the second-generation antitumor taxoids. Exceptional activity against drug-resistant cancer cells. J Med Chem 39: 3889-3896, 1996. (Pubitemid 26327426)
19. Ehrlichová M, Václavíková R, Ojima I, Pepe A, Kuznetsova LV, Chen J, Truksa J, Kovář J and Gut I: Transport and cytotoxicity of paclitaxel, docetaxel, and novel taxanes in human breast cancer cells. N-S Arch Pharmacol 372: 95-105, 2005. (Pubitemid 41414050)
20. Ferlini C, Raspaglio G, Mozzetti S, Cicchillitti L, Filippetti F, Gallo D, Fattorusso C, Campiani G and Scambia G: The secotaxane IDN5390 is able to target class III beta-tubulin and to overcome paclitaxel resistance. Cancer Res 65: 2397-2405, 2005. (Pubitemid 40490151)
21. Rowinsky EK and Calvo E: Novel agents that target tubulin and related elements. Semin Oncol 33: 421-435, 2006.
22. Musílková J and Kovář J: Additive stimulatory effect of extracellular calcium and potassium on non-transferrin ferric iron uptake by HeLa and K562 cells. Biochim Biophys Acta 1514: 117-126, 2001.
23. Kovář J, Valenta T and Štýbrová H: Differing sensitivity of tumor cells to apoptosis induced by iron deprivation in vitro. In Vitro Cell Dev Biol Anim 37: 450-458, 2001. (Pubitemid 32880543)
24. Koc M, Nad'ová Z, Truksa J, Ehrlichová M and Kovář J: Iron deprivation induces apoptosis via mitochondrial changes related to Bax translocation. Apoptosis 10: 381-393, 2005.
25. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ and Klenk DC: Measurement of protein using bicinchoninic acid. Anal Biochem 150: 76-85, 1985.
26. Chen JG, Yang CP, Cammer M and Horwitz SB: Gene expression and mitotic exit induced by microtubule-stabilizing drugs. Cancer Res 63: 7891-7899, 2003. (Pubitemid 37466724)
27. Ikui AE, Yang CH, Matsumoto T and Horwitz SB: Low concentrations of taxol cause mitotic delay followed by premature dissociation of p55CDC from Mad2 and BubR1 and abrogation of the spindle checkpoint, leading to aneuploidy. Cell Cycle 4: 1385-1388, 2005. (Pubitemid 41437128)
28. Estève MA, Carré M and Braguer D: Microtubules in apoptosis induction: are they necessary? Curr Cancer Drug Targets 7: 325-334, 2007.
29. Torres K and Horwitz SB: Mechanisms of taxol-induced cell death are concentration dependent. Cancer Res 58: 3620-3626, 1998. (Pubitemid 28376560)
30. Kottke TJ, Blajeski AL, Martins LM, Mesner PW Jr, Davidson NE, Earnshaw WC, Armstrong DK and Kaufmann SH: Comparison of paclitaxel-, 5-fluoro-2′-deoxyuridine-, and epidermal growth factor (EGF)-induced apoptosis. Evidence for EGF-induced anoikis. J Biol Chem 274: 15927-15936, 1999. (Pubitemid 129518958)
31. Friedrich K, Wieder T, Von Haefen C, Radetzki S, Janicke R, Schulze-Osthoff K, Dorken B and Daniel PT: Overexpression of caspase-3 restores sensitivity for drug-induced apoptosis in breast cancer cell lines with acquired drug resistance. Oncogene 20: 2749-2760, 2001. (Pubitemid 32549832)
32. André N, Carré M, Brasseur G, Pourroy B, Kovacic H, Briand C and Braguer D: Paclitaxel targets mitochondria upstream of caspase activation in intact human neuroblastoma cells. FEBS Lett 532: 256-260, 2002. (Pubitemid 35375900)
33. Kolfschoten G, Hulscher TM, Duyndam MCA, Pinedo HM and Boven E: Variation in the kinetics of caspase-3 activation, Bcl-2 phosphorylation and apoptotic morphology in unselected human ovarian cancer cell lines as a response to docetaxel. Biochem Pharmacol 63: 733-743, 2002.
34. Jiang S, Zu Y, Fu Y, Zhang Y and Efferth T: Activation of the mitochondria-driven pathway of apoptosis in human PC-3 prostate cancer cells by a novel hydrophilic paclitaxel derivative, 7-xylosyl-10-deacetylpaclitaxel. Int J Oncol 33: 103-111, 2008.
35. Zhivotovsky B and Orrenius S: Caspase-2 function in response to DNA damage. Biochem Biophys Res Commun 331: 859-867, 2005. (Pubitemid 40615517)
36. Ho LH, Read SH, Dorstyn L, Lambrusco L and Kumar S: Caspase-2 is required for cell death induced by cytoskeletal disruption. Oncogene 27: 3393-3404, 2008. (Pubitemid 351769315)
37. Yuan SY, Hsu SL, Tsai KJ and Yang CR: Involvement of mitochondrial pathway in taxol-induced apoptosis of human T24 bladder cancer cells. Urol Res 30: 282-288, 2002. (Pubitemid 36056636)
38. Wang YF, Chen CY, Chung SF, Chiou YH and Lo HR: Involvement of oxidative stress and caspase activation in paclitaxel-induced apoptosis of primary effusion lymphoma cells. Cancer Chemother Pharmacol 54: 322-330, 2004. (Pubitemid 39304427)
39. Mhaidat NM, Wang Y, Kiejda KA, Zhang XD and Hersey P: Docetaxel-induced apoptosis in melanoma cells is dependent on activation of caspase-2. Mol Cancer Ther 6: 752-761, 2007. (Pubitemid 46332476)
40. Chen H, Chung S and Sukumar S: HOXA5-induced apoptosis in breast cancer cells is mediated by caspase 2 and 8. Mol Cell Biol 24: 924-935, 2004. (Pubitemid 38057941)
41. Mansilla S, Priebe W and Portugal J: Mitotic catastrophe results in cell death by caspase-dependent and caspase-independent mechanisms. Cell Cycle 5: 53-60, 2006.
42. Das S, Nwachukwu JC, Li D, Vulin AI, Martinez-Caballero S, Kinnally KW and Samuels HH: The nuclear receptor interacting factor-3 transcriptional coregulator mediates rapid apoptosis in breast cancer cells through direct and bystander-mediated events. Cancer Res 67: 1775-1782, 2007. (Pubitemid 46383405)